Caricamento...
Organoprotective effects of serelaxin in patients with severe decompensated heart failure
Serelaxin (recombinant molecule of the human relaxin-2) is an innovative drug for the treatment of acute heart failure. Preclinical and clinical studies demonstrated the ability of serelaxin to relieve the symptoms of heart failure, provide a significant reduction in congestion and have a protective...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Stolichnaya Izdatelskaya Kompaniya
2016-09-01
|
| Serie: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| Soggetti: | |
| Accesso online: | https://www.rpcardio.com/jour/article/view/1305 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|